Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KeyGene is a leading independent agricultural biotechnology research company specializing in developing breakthrough technologies to accelerate crop improvement. It provides genomics-based seed design, marker-assisted selection, genome editing (including non-transgenic methods), digital phenotyping, and trait discovery platforms to global partners. The company's innovations have enabled advances such as disease-resistant varieties and improved yield/quality in vegetables, fruits, ornamentals, and field crops.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KeyGene.